
[email protected]
Corey Casper
President & CEO at Access to Advanced Health Institute; Former Chief Medical Officer at the Infectious Disease Research Institute
Corey Casper is an accomplished scientific leader with 20 years of experience designing, growing and sustaining internationally-recognized programs in infectious diseases, HIV, cancer and rare diseases. As President and CEO at Access to Advanced Health Institute, Casper is responsible for strategy, financial management and growth, stakeholder relationships and governance of the independent non-profit global health biotech.
Previously, Casper was the Chief Medical Officer at the Infectious Disease Research Institute, where he was in charge of advancing a portfolio of vaccines, immunotherapeutics, and diagnostic tests through the clinical pipeline from pre-clinical to Phase 2 studies. He also worked as Professor in the Vaccine and Infectious Disease, Clinical Research and Public Health Sciences Divisions at the Fred Hutchinson Cancer Research Center, where he founded and directed one of the nation’s first and most effective outpatient infection control programs; he also founded and directed the first Global Oncology program at a designated comprehensive cancer center. At the University of Washington, he was appointed as a Professor of Medicine, Epidemiology and Global Health, and served as the Co-Director of the Center for AIDS Research. He has held several clinical positions, including serving as an attending physician for the Seattle Cancer Care Alliance’s Infectious Disease Consult Service.
Casper obtained an undergraduate degree in Biology from Wesleyan University, his M.D. from Cornell University Medical College, and a Master of Public Health degree from the University of Washington.
Related Speakers View all
![]() |
Marty Makary, M.D.
Commissioner of the U.S. FDA; Healthcare Futurist, J...
|
![]() |
Marcella Nunez-Smith
Associate Dean for Health Equity Research & Professo...
|
![]() |
Dr. Elizabeth Jaffee
International Leader in Immune Based Therapies for P...
|
![]() |
Dr. Laura Esserman
Surgeon & Breast Cancer Oncology Specialist at UCSF;...
|
![]() |
Leonard I. Zon
Cancer Genetics & Stem Cell Biology Researcher; Prof...
|
![]() |
Barbara Bowers, MD
Medical Oncologist Specialized in the Diagnosis & Tr...
|
![]() |
Douglas Yee, MD
Director of the Masonic Cancer Center at the Univers...
|
![]() |
Andy Schmeltz
Global President and General Manager, Pfizer Oncology
|
![]() |
Tisha Rowe
Family Medicine Physician & Entrepreneur
|
![]() |
Yehia Abugabal
Founder & Director at International Cancer Research ...
|
![]() |
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|
![]() |
Nikhil Wagle
Director, Count Me In, Broad Institute
|
![]() |
Steven Burakoff
Dean for Cancer Innovation & Chief of Pediatric Hema...
|
![]() |
Dr. Jen Gunter
OB/GYN, Pain Medicine Specialist, Reproductive Healt...
|
![]() |
Katrina Armstrong
Chief Executive Officer of the Columbia University I...
|
![]() |
Josh Allen
Director of Development at Oncoceutics, Forbes 30 Un...
|
![]() |
Laurie H. Glimcher
President & CEO of Dana-Farber Cancer Institute; Can...
|
![]() |
Otis Brawley
Oncology Expert, Epidemiologist, Cancer Disparities ...
|
![]() |
Monica Bertagnolli
Director at National Institutes of Health
|
![]() |
William K. Oh
Chief Medical Officer at the Prostate Cancer Foundation
|